For example, ATRA and arsenic treatment degrades PML-RAR and alleviates the differentiation block, despite the remained chromosomal translocation, suggesting that enhancer hijacking is not the primary driver of the APL associated differentiation block. The gene discussed is PML; the disease is acute promyelocytic leukemia.